{ { Drugbox
| verifiedrevid = 451218082
| IUPAC_name = ''N-benzyl-2,2-dimethyl-propanehydrazide
| image = Pivalylbenzhydrazine.svg
| width = 150px
| tradename =
| pregnancy_category =
| legal_status = Rx-only
| routes_of_administration = Oral
| bioavailability =
| metabolism =
| elimination_half-life =
| excretion =
| CAS_number_Ref =
| CAS_number = 306-19-4
| UNII_Ref =
| UNII = TK1T520ASG
| ATC_prefix = none
| ATC_suffix =
| PubChem = 9375
| ChEMBL = 2106941
| ChemSpiderID_Ref =
| ChemSpiderID = 9007
| C=12 | H=18 | N=2 | O=1
| StdInChI_Ref =
| StdInChI = 1S/C12H18N2O/c1-12(2,3)11(15)14-13-9-10-7-5-4-6-8-10/h4-8,13H,9H2,1-3H3,(H,14,15) | StdInChIKey_Ref = | StdInChIKey = FWWDFDMCZLOXQI-UHFFFAOYSA-N | synonyms = Angorvid, Betamezid, Neomarsilid, Pivazide, Pivhydrazine }}Pivhydrazine (trade name Tersavid), also known as pivalylbenzhydrazine and pivazide''', is an irreversible and non-selective monoamine oxidase inhibitor (MAOI) of the hydrazine family. It was formerly used as an antidepressant in the 1960s, but has since been discontinued.
See also
Hydrazine (antidepressant)